ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Tuesday reported a loss of $30.4 million in its fourth quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of 62 cents.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 71 cents per share.
The biopharmaceutical company posted revenue of $25.2 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $10.7 million.
For the year, the company reported that its loss narrowed to $151.8 million, or $3.16 per share. Revenue was reported as $64.2 million.sonos sonos One (Gen 2) - Voice Controlled Smart Speaker with Amazon Alexa Built-in - Black read more
MacroGenics shares have risen 1% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $10.99, a decline of 49% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX
all right reserved for yahoo news